Rocket Lab USA is trading at $63.34, down 4.85%, amid concerns over Neutron’s narrowing 2026 launch window.
- October 13 coverage also cited CFO Adam Spice’s disclosed stock sale as a pressure on shares.
- The sale involved 140,157 shares on October 1 under a 10b5-1 plan; it is a reported potential overhang, not proof of the day’s cause.
- Broader indices were mixed, with no major same-direction move evident; no new company announcement clearly explains the decline.